SEC Form 4 · accession 0001209191-18-060644
ImmunityBio, Inc. · IBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Gorlin
Director
Period of report
Nov 29, 2018
Accepted (ET)
Dec 3, 2018 · 5:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 29, 2018 | S | 138,349 | $1.65 | D | 0 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.